Real-time enrollment status for this antithrombin deficiency clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT04918173 |
| Recruiting Status | Recruiting |
| Condition | Antithrombin Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 38 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Octapharma |
| Last Updated on CT.gov | November 21, 2025 (Nov 21, 2025) |
As of March 2, 2026: Clinical trial NCT04918173 is currently recruiting participants. This clinical trial study for antithrombin deficiency is actively seeking new participants at 5 locations across the United States. The study is sponsored by Octapharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04918173 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04918173 was last updated Nov 21, 2025 (November 21, 2025). HelloStudys verifies this status automatically.